Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease

被引:0
|
作者
S. Tok
H. Maurin
C. Delay
D. Crauwels
N. V. Manyakov
W. Van Der Elst
D. Moechars
W. H. I. M. Drinkenburg
机构
[1] Janssen Pharmaceutica NV,Department of Neuroscience, Janssen Research and Development
[2] Janssen Pharmaceutica NV,Data Sciences, Janssen Research and Development
[3] Janssen Pharmaceutica NV,Quantitative Sciences Janssen Research and Development
[4] University of Groningen,Groningen Institute for Evolutionary Life Sciences, Faculty of Science and Engineering
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The two main histopathological hallmarks that characterize Alzheimer’s Disease are the presence of amyloid plaques and neurofibrillary tangles. One of the current approaches to studying the consequences of amyloid pathology relies on the usage of transgenic animal models that incorporate the mutant humanized form of the amyloid precursor protein (hAPP), with animal models progressively developing amyloid pathology as they age. However, these mice models generally overexpress the hAPP protein to facilitate the development of amyloid pathology, which has been suggested to elicit pathological and neuropathological changes unrelated to amyloid pathology. In this current study, we characterized APP knock-in (APP-KI) animals, that do not overexpress hAPP but still develop amyloid pathology to understand the influence of protein overexpression. We also induced tau pathology via human-derived tau seeding material to understand the neurophysiological effects of amyloid and tau pathology. We report that tau-seeded APP-KI animals progressively develop tau pathology, exacerbated by the presence of amyloid pathology. Interestingly, older amyloid-bearing, tau-seeded animals exhibited more amyloid pathology in the entorhinal area, isocortex and hippocampus, but not thalamus, which appeared to correlate with impairments in gamma oscillations before seeding. Tau-seeded animals also featured immediate deficits in power spectra values and phase-amplitude indices in the hippocampus after seeding, with gamma power spectra deficits persisting in younger animals. Both deficits in hippocampal phase-amplitude coupling and gamma power differentiate tau-seeded, amyloid-positive animals from buffer controls. Based on our results, impairments in gamma oscillations appear to be strongly associated with the presence and development of amyloid and tau pathology, and may also be an indicator of neuropathology, network dysfunction, and even potential disposition to the future development of amyloid pathology.
引用
收藏
相关论文
共 18 条
  • [1] Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease
    Tok, S.
    Maurin, H.
    Delay, C.
    Crauwels, D.
    Manyakov, N., V
    Van der Elst, W.
    Moechars, D.
    Drinkenburg, W. H. I. M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [2] Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP NL-G-F adult offspring NL-G-F/NL-G-F mice
    Hossain, Shakhawat R.
    Karem, Hadil
    Jafari, Zahra
    Kolb, Bryan E.
    Mohajerani, Majid H.
    EXPERIMENTAL NEUROLOGY, 2023, 368
  • [3] Lysosomal Dysregulation in the Murine AppNL-G-F/NL-G-F Model of Alzheimer's Disease
    Whyte, Lauren S.
    Hassiotis, Sofia
    Hattersley, Kathryn J.
    Hemsley, Kim M.
    Hopwood, John J.
    Lau, Adeline A.
    Sargeant, Timothy J.
    NEUROSCIENCE, 2020, 429 : 143 - 155
  • [4] Regional contributions of D-serine to Alzheimer's disease pathology in male AppNL-G-F/NL-G-F mice
    Ni, Xiance
    Inoue, Ran
    Wu, Yi
    Yoshida, Tomoyuki
    Yaku, Keisuke
    Nakagawa, Takashi
    Saito, Takashi
    Saido, Takaomi C.
    Takao, Keizo
    Mori, Hisashi
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [5] Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer’s disease
    S. Tok
    H. Maurin
    C. Delay
    D. Crauwels
    N. V. Manyakov
    W. Van Der Elst
    D. Moechars
    W. H. I. M. Drinkenburg
    Scientific Reports, 12
  • [6] Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F/NL-G-F) model of Alzheimer's disease
    Mehla, Jogender
    Lacoursiere, Sean G.
    Lapointe, Valerie
    McNaughton, Bruce L.
    Sutherland, Robert J.
    McDonald, Robert J.
    Mohajerani, Majid H.
    NEUROBIOLOGY OF AGING, 2019, 75 : 25 - 37
  • [7] Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease
    Tok, S.
    Maurin, H.
    Delay, C.
    Crauwels, D.
    Manyakov, N., V
    Van der Elst, W.
    Moechars, D.
    Drinkenburg, W. H. I. M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] ERβ mediates sex-specific protection in the App-NL-G-F mouse model of Alzheimer’s disease
    Aphrodite Demetriou
    Birgitta Lindqvist
    Heba G. Ali
    Mohamed M. Shamekh
    Mukesh Varshney
    Jose Inzunza
    Silvia Maioli
    Per Nilsson
    Ivan Nalvarte
    Biology of Sex Differences, 16 (1)
  • [9] Detection of Amyloid β Oligomers with RNA Aptamers in AppNL-G-F/NL-G-F Mice: A Model of Arctic Alzheimer's Disease
    Obata, Yayoi
    Murakami, Kazuma
    Kawase, Taiji
    Hirose, Kenji
    Izuo, Naotaka
    Shimizu, Takahiko
    Irie, Kazuhiro
    ACS OMEGA, 2020, 5 (34): : 21531 - 21537
  • [10] Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model
    Ge, Yingying
    AlObaidi, Alya S.
    Kuchel, George A.
    Bartley, Jenna M.
    Smith, Phillip P.
    He, Wanxia
    Hu, Xiangyou
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (01) : 395 - 408